PROFUSA PE Ratio 2022-2025 | PFSA
Current and historical p/e ratio for PROFUSA (PFSA) from 2022 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. PROFUSA PE ratio as of February 09, 2026 is 0.00.
| PROFUSA PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-02-09 | 3.16 | 0.00 | |
| 2025-09-30 | 22.27 | $-2.23 | 0.00 |
| 2025-06-30 | 938.25 | $-1.53 | 0.00 |
| 2025-03-31 | 907.50 | 0 | 0.00 |
| 2024-09-30 | 877.50 | 0 | 0.00 |
| 2024-06-30 | 862.50 | 0 | 0.00 |
| 2024-03-31 | 845.25 | 0 | 0.00 |
| 2023-12-31 | 837.00 | 0 | 0.00 |
| 2023-09-30 | 809.26 | 0 | 0.00 |
| 2023-06-30 | 785.25 | 0 | 0.00 |
| 2023-03-31 | 775.50 | 0 | 0.00 |
| 2022-12-31 | 759.75 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.004B | $0.000B |
| Profusa Inc. is a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual's biochemistry. Profusa Inc., formerly known as NorthView Acquisition Corp., is based in BERKELEY, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $30.347B | 35.10 |
| Tempus AI (TEM) | United States | $10.162B | 0.00 |
| Doximity (DOCS) | United States | $5.177B | 22.00 |
| IRhythm Holdings (IRTC) | United States | $4.785B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.400B | 35.80 |
| Privia Health (PRVA) | United States | $2.661B | 166.38 |
| Hinge Health (HNGE) | United States | $2.532B | 0.00 |
| Heartflow (HTFL) | United States | $2.494B | 0.00 |
| 10x Genomics (TXG) | United States | $2.346B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $1.927B | 31.89 |
| Omnicell (OMCL) | United States | $1.638B | 45.62 |
| Azenta (AZTA) | United States | $1.373B | 55.19 |
| Enovis (ENOV) | United States | $1.279B | 6.71 |
| Clover Health Investments (CLOV) | United States | $1.080B | 0.00 |
| Schrodinger (SDGR) | United States | $1.002B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.841B | 0.00 |
| Phreesia (PHR) | United States | $0.737B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.709B | 0.00 |
| Talkspace (TALK) | United States | $0.639B | 128.67 |
| Standard BioTools (LAB) | United States | $0.485B | 0.00 |
| Claritev (CTEV) | United States | $0.393B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.329B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.328B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.325B | 0.00 |
| Carlsmed (CARL) | United States | $0.320B | 0.00 |
| Evolent Health (EVH) | United States | $0.305B | 0.00 |
| TruBridge (TBRG) | United States | $0.296B | 13.59 |
| CapsoVision (CV) | United States | $0.237B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.221B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.205B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.173B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.161B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.153B | 0.00 |
| CareCloud (CCLD) | United States | $0.097B | 5.30 |
| Outset Medical (OM) | United States | $0.084B | 0.00 |
| American Well (AMWL) | United States | $0.070B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| Pulmonx (LUNG) | United States | $0.064B | 0.00 |
| 111 (YI) | China | $0.062B | 0.00 |
| HeartBeam (BEAT) | United States | $0.049B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.045B | 0.00 |
| Precipio (PRPO) | United States | $0.035B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.029B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.019B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.018B | 0.00 |
| Movano (MOVE) | United States | $0.012B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.007B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.006B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |